•
Mar 31, 2023

TruBridge Q1 2023 Earnings Report

CPSI's first quarter results were announced, showcasing revenue growth and strategic focus on RCM business.

Key Takeaways

CPSI reported an 11% increase in total revenue compared to Q1 2022, driven by a 20% growth in TruBridge revenue cycle management (RCM) revenue. The company's strategy to focus on the RCM business is gaining traction, with RCM bookings growing by 41%.

Total revenue increased by 11% compared to the first quarter of 2022.

TruBridge RCM revenue grew by 20% compared to the first quarter of 2022.

RCM revenue accounted for 56% of CPSI's total revenue.

The company saw continued success in winning new clients and cross-selling RCM solutions.

Total Revenue
$86.2M
Previous year: $77.9M
+10.7%
EPS
$0.58
Previous year: $0.81
-28.4%
Gross Profit
$42.1M
Previous year: $41.2M
+2.1%
Cash and Equivalents
$6.82M
Previous year: $16M
-57.3%
Free Cash Flow
$9.46M
Previous year: $11.8M
-19.8%
Total Assets
$437M
Previous year: $440M
-0.8%

TruBridge

TruBridge

Forward Guidance

CPSI's first quarter 2023 results position them well to achieve their 2023 outlook.

Positive Outlook

  • Strategy to shift focus towards RCM business gaining traction.
  • RCM pipeline strengthened.
  • RCM bookings grew by 41%.
  • Nearly half of RCM bookings came from cross-sell opportunities.
  • Momentum in RCM business is a result of strengthening relationships with loyal EHR customer base, prioritizing the enhancement of sales team, and committing to continued growth.